Bioventus (BVS) Profit After Tax (2020 - 2026)
Bioventus (BVS) posted Profit After Tax of $2.7 million for Q1 2026, down 81.39% on a QoQ basis from $14.7 million in Q4 2025, and up 203.68% year-over-year from $900294.5 in Q1 2025.
Bioventus (BVS) Profit After Tax (2020 - 2026) Analysis & Trends
Bioventus' Profit After Tax history runs 7 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- Quarterly Profit After Tax rose 203.68% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.2 million (up 171.04% YoY) and the FY2025 annual result came in at $23.4 million, up 164.79% from the prior year.
- Profit After Tax was $2.7 million for Q1 2026 at Bioventus, down from $14.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at $23.9 million in Q4 2022 and bottomed at -$173.8 million in Q2 2023.
- A 5-year average of -$16.5 million and a median of -$5.2 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax slumped 2664.06% — and 2025, when it jumped 37771.79%.
- Bioventus' Profit After Tax stood at $23.9 million in 2022, then plunged by 132.08% to -$7.7 million in 2023, then soared by 99.49% to -$39000.0 in 2024, then soared by 37771.79% to $14.7 million in 2025, then slumped by 81.39% to $2.7 million in 2026.
- Business Quant data shows BVS's Profit After Tax at $2.7 million in Q1 2026, $14.7 million in Q4 2025, and $4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | 380.70 Mn |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 199.50 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 170.93 Mn |
| 10 | Bioventus | 825.05 Mn | 789.21 Mn | 90.77 Mn | 2.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 2.73 Mn |
| Dec 31, 2025 | 14.69 Mn |
| Sep 27, 2025 | 4.01 Mn |
| Jun 28, 2025 | 8.75 Mn |
| Mar 29, 2025 | -2.64 Mn |
| Dec 31, 2024 | -39,000.00 |
| Sep 28, 2024 | -5.17 Mn |
| Jun 29, 2024 | -34.64 Mn |
| Mar 30, 2024 | -6.38 Mn |
| Dec 31, 2023 | -7.66 Mn |
| Sep 30, 2023 | -8.79 Mn |
| Jul 1, 2023 | -3.68 Mn |
| Apr 1, 2023 | -173.79 Mn |
| Dec 31, 2022 | 23.87 Mn |
| Oct 1, 2022 | -72.83 Mn |
| Jul 2, 2022 | -6.97 Mn |
| Apr 2, 2022 | -11.28 Mn |
| Dec 31, 2021 | 32.62 Mn |
| Oct 2, 2021 | -2.64 Mn |
| Jul 3, 2021 | -4.11 Mn |